1641 SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice.
https://www.pnas.org/doi/10.1073/pnas.2302083120
1640 A role for the Gram-negative outer membrane in bacterial shape determination.
https://www.pnas.org/doi/10.1073/pnas.2301987120
1639 The gut microbiota reprograms intestinal lipid metabolism through long noncoding RNA Snhg9.
https://www.science.org/doi/10.1126/science.ade0522
1638 Structure-based design of a SARS-CoV-2 Omicron-specific inhibitor.
https://www.pnas.org/doi/10.1073/pnas.2300360120
1637 Influence of glycan structure on the colonization of Streptococcus pneumoniae on human respiratory epithelial cells.
https://www.pnas.org/doi/10.1073/pnas.2213584120
1636 Inhibition of peptidoglycan synthesis is sufficient for total arrest of staphylococcal cell division.
https://www.science.org/doi/10.1126/sciadv.ade9023
1635 An innate pathogen sensing strategy involving ubiquitination of bacterial surface proteins.
https://www.science.org/doi/10.1126/sciadv.ade1851
1634 Blocking NS3–NS4B interaction inhibits dengue virus in non-human primates.
https://www.nature.com/articles/s41586-023-05790-6
1633 Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection.
https://www.pnas.org/doi/10.1073/pnas.2219523120
1632 Diverse yeast antiviral systems prevent lethal pathogenesis caused by the L-A mycovirus.
https://www.pnas.org/doi/10.1073/pnas.2208695120
|
